SANGAMO THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $69.60 million as of 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2021-02-24
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $69.60M.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $7.50M.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $24.50M.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $71.70M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2020-12-31 | $69.60M 10-K · filed 2021-02-24 |
| 2019-12-31 | $7.50M 10-K · filed 2021-02-24 |
| 2018-12-31 | $24.50M 10-K · filed 2021-02-24 |
| 2017-12-31 | $71.70M 10-K · filed 2020-02-28 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
| 2015-12-31 | $14.00M 10-K · filed 2018-03-01 |
| 2014-12-31 | $49.40M 10-K · filed 2017-02-28 |
| 2013-12-31 | $54.90M 10-K · filed 2016-02-18 |
| 2012-12-31 | $8.50M 10-K · filed 2015-02-25 |
| 2011-12-31 | $100.00K 10-K · filed 2014-02-24 |
| 2010-12-31 | $11.20M 10-K · filed 2013-02-26 |